2026摩根大通医疗健康周：聚焦授权交易与定价政策

Core Insights - The JPM Healthcare Week, regarded as the most important week in the global biopharmaceutical, medical device, and healthcare technology sectors, takes place annually in January in San Francisco [1][2] - The focus of the 2026 JPM Healthcare Conference will be on licensing deals and pricing policies, rather than large mergers and acquisitions [1][2] - Companies such as AbbVie (ABBV), Novartis (NVS), Revolution Medicines (RVMD), and Abivax (ABVX) may be impacted by discussions surrounding licensing deals and drug pricing policies [1][2]